Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
05-2013 | 03-2013 | 02-2013 | 12-2012 | 11-2012 | |
Operating Expenses | 0 | 1,380 | 0 | 1,640 | 0 |
Operating Income | N/A | -1,380 | N/A | -1,640 | N/A |
Other Income | 0 | 10 | 0 | 10 | 0 |
Pre-tax Income | 0 | -1,370 | 0 | -1,630 | 0 |
Net Income Continuous | N/A | -1,350 | N/A | -1,588 | N/A |
Net Income | $N/A | $-1,350 | $N/A | $-1,588 | $N/A |
EPS Basic Total Ops | N/A | -5.40 | N/A | -7.20 | N/A |
EPS Basic Continuous Ops | N/A | -5.75 | N/A | -6.76 | N/A |
EPS Diluted Total Ops | N/A | -5.40 | N/A | -7.20 | N/A |
EPS Diluted Continuous Ops | N/A | -5.75 | N/A | -6.76 | N/A |
EBITDA(a) | $N/A | $-1,360 | $N/A | $-1,640 | $N/A |